Singapore, April 21 -- Taipei Medical University (TMU) and Merck Sharp & Dohme (MSD) Taiwan have signed a Memorandum of Understanding to collaborate in six key directions aiming to advance healthcare in Taiwan.

This partnership, the very first large-scale alliance between a global pharmaceutical company and a medical university in Taiwan, will inject international resources into the country's healthcare innovation ecosystem and enhance its biotechnology and pharmaceutical competitiveness.

TMU Office of Business Development will form the "MSD Innovative Strategic Partnership" with industry experts at MSD to provide business mentorship, clinical validation, and collaboration with startups.

TMU Office of Human Research will work with clin...